“

At a time when drug policy is being reevaluated, when marijuana looks like it's on the road toward legalization, when psychedelic medicine is moving forward through the FDA and we can envision a time when psychedelics are available as prescription medicines, how ayahuasca should be handled in a regulatory context is really up in the air.